122 related articles for article (PubMed ID: 35569305)
1. Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer.
Chen QY; Zhou WJ; Zhang JG; Zhang X; Han QY; Lin A; Yan WH
Int Immunopharmacol; 2022 Aug; 109():108798. PubMed ID: 35569305
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A
Front Immunol; 2021; 12():679090. PubMed ID: 34054869
[TBL] [Abstract][Full Text] [Related]
3. Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients.
Hoffmann O; Wormland S; Bittner AK; Hölzenbein J; Schwich E; Schramm S; Rohn H; Horn PA; Kimmig R; Kasimir-Bauer S; Rebmann V
Front Immunol; 2023; 14():1188030. PubMed ID: 37283737
[TBL] [Abstract][Full Text] [Related]
4. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
5. Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary.
Schwich E; Hò GT; LeMaoult J; Bade-Döding C; Carosella ED; Horn PA; Rebmann V
Front Immunol; 2020; 11():2046. PubMed ID: 32973812
[TBL] [Abstract][Full Text] [Related]
6. Elevation of HLA-G-expressing DC-10 cells in patients with gastric cancer.
Xu DP; Shi WW; Zhang TT; Lv HY; Li JB; Lin A; Yan WH
Hum Immunol; 2016 Sep; 77(9):800-4. PubMed ID: 26773190
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
Xu HH; Gan J; Xu DP; Li L; Yan WH
Front Immunol; 2021; 12():614773. PubMed ID: 34276642
[TBL] [Abstract][Full Text] [Related]
8. Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients.
Rohn H; Schramm S; Pansikaki K; Jansen S; Hendriks C; Platte M; Konik MJ; Dolff S; Wilde B; Kordelas L; Trilling M; Krawczyk A; Horn PA; Witzke O; Rebmann V
Hum Immunol; 2023 Aug; 84(8):393-400. PubMed ID: 36925435
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of HLA-G and ILT-2 receptor in human tuberculosis: Localized versus disseminated disease.
Saurabh A; Thakral D; Mourya MK; Singh A; Mohan A; Bhatnagar AK; Mitra DK; Kanga U
Hum Immunol; 2016 Sep; 77(9):746-53. PubMed ID: 26776460
[TBL] [Abstract][Full Text] [Related]
10. Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer.
Mejía-Guarnizo LV; Monroy-Camacho PS; Rincón-Rodríguez DE; Rincón-Riveros A; Martinez-Vargas DA; Huertas-Caro CA; Oliveros-Wilches R; Sanchez-Pedraza R; Nuñez-Lemus M; Cristancho-Lievano CF; Castellanos-Moreno AM; Martinez-Correa LM; Rodríguez-García JA
Sci Rep; 2023 Aug; 13(1):13119. PubMed ID: 37573450
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting HLA-G restores IFN-γ and TNF-α producing T cell in pleural Tuberculosis.
Saurabh A; Chakraborty S; Kumar P; Mohan A; Bhatnagar AK; Rishi N; Mitra DK
Tuberculosis (Edinb); 2018 Mar; 109():69-79. PubMed ID: 29559123
[TBL] [Abstract][Full Text] [Related]
12. HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact.
Murdaca G; Calamaro P; Lantieri F; Pigozzi S; Mastracci L; Grillo F; Magnani O; Ceppa P; Puppo F; Fiocca R
Virchows Arch; 2018 Oct; 473(4):425-433. PubMed ID: 29845360
[TBL] [Abstract][Full Text] [Related]
13. Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells.
Rohn H; Lang C; Schramm S; Heinemann FM; Trilling M; Gäckler A; Witzke O; Horn PA; Rebmann V
J Immunol Res; 2022; 2022():4829227. PubMed ID: 35600048
[TBL] [Abstract][Full Text] [Related]
14. [Applications of monitoring human leukocyte antigen G and its inhibitory receptors in post-renal transplantation].
XIAO L; SHI BY; GAO Y; CAI M; Qian YY; HE XY; XU XG; HAN Y; ZHOU WQ; MENG XY; HAN MX
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(36):2524-7. PubMed ID: 21092455
[TBL] [Abstract][Full Text] [Related]
15. The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
Attia JVD; Dessens CE; van de Water R; Houvast RD; Kuppen PJK; Krijgsman D
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213057
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells.
Du L; Xiao X; Wang C; Zhang X; Zheng N; Wang L; Zhang X; Li W; Wang S; Dong Z
Cancer Sci; 2011 Jul; 102(7):1272-80. PubMed ID: 21466615
[TBL] [Abstract][Full Text] [Related]
17. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.
Naji A; Durrbach A; Carosella ED; Rouas-Freiss N
Hum Immunol; 2007 Apr; 68(4):233-9. PubMed ID: 17400057
[TBL] [Abstract][Full Text] [Related]
18. TGF-β induces HLA-G expression through inhibiting miR-152 in gastric cancer cells.
Guan Z; Song B; Liu F; Sun D; Wang K; Qu H
J Biomed Sci; 2015 Dec; 22():107. PubMed ID: 26627200
[TBL] [Abstract][Full Text] [Related]
19. Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance.
Zhang Y; Lu N; Xue Y; Zhang M; Li Y; Si Y; Bian X; Jia Y; Wang Y
Mol Med Rep; 2012 Apr; 5(4):910-6. PubMed ID: 22246571
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.
Loumagne L; Baudhuin J; Favier B; Montespan F; Carosella ED; Rouas-Freiss N
Int J Cancer; 2014 Nov; 135(9):2107-17. PubMed ID: 24623585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
